Atlas Trials

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Clinical trial NCT04684147 · RECRUITING

Trial details

NCT number
NCT04684147
Sponsor
Juventas Cell Therapy Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Lymphoblastic Leukemia
Start date
2020-12-24
Primary completion
2022-09-22
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.